Nathaniel is an Assistant Professor at the A.J. Drexel Autism Institute. His current work focuses on identifying and measuring modifiable risk factors for autism spectrum disorder (ASD). The long term goals of this work are to bridge population and individual level scientific approaches and develop a public health approach to prevention of ASD.
Nathaniel studied Biochemistry at the University of Maryland and trained at the National Institutes of Health. Dr. Snyder’s Ph.D. thesis in Pharmacology at the University of Pennsylvania concerned analytical measurements of low abundance biological molecules using liquid chromatography-mass spectrometry (LC-MS). Also completed at the University of Pennsylvania, Dr. Snyder’s MPH work investigated non-invasive biomarkers of asbestos exposure, and contributed to the Penn Superfund Research and Training Program. Nathaniel has published and presented academic works on analytical chemistry, metabolism, inflammation, and environmental exposure assessment.
Current research projects include studies of environmental exposures, metabolic pathways involved in neurodevelopment, and molecular mechanisms that may mediate ASD. Additional projects include fundamental work on improving sample collection and analysis, as well as refining epidemiological trial design using laboratory measurements. Nathaniel staffs the Exposure Science Lab at the Autism Institute.